639 related articles for article (PubMed ID: 9721879)
21. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
Hala M; Hartmann BL; Böck G; Geley S; Kofler R
Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor.
Zawydiwski R; Harmon JM; Thompson EB
Cancer Res; 1983 Aug; 43(8):3865-73. PubMed ID: 6134583
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase A (PKA) isoform RIIbeta mediates the synergistic killing effect of cAMP and glucocorticoid in acute lymphoblastic leukemia cells.
Ji Z; Mei FC; Miller AL; Thompson EB; Cheng X
J Biol Chem; 2008 Aug; 283(32):21920-5. PubMed ID: 18544528
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells.
Heidari N; Miller AV; Hicks MA; Marking CB; Harada H
Cell Death Dis; 2012 Jul; 3(7):e349. PubMed ID: 22825467
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia.
Qattan MY; Bakker EY; Rajendran R; Chen DW; Saha V; Liu J; Zeef L; Schwartz JM; Mutti L; Demonacos C; Krstic-Demonacos M
PLoS One; 2017; 12(6):e0178606. PubMed ID: 28582465
[TBL] [Abstract][Full Text] [Related]
26. The glucocorticoid receptor is increased in Atm-/- thymocytes and in Atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression.
Yan M; Kuang X; Scofield VL; Shen J; Lynn WS; Wong PK
Steroids; 2007 May; 72(5):415-21. PubMed ID: 17418878
[TBL] [Abstract][Full Text] [Related]
27. Use of recombinant cell-permeable small peptides to modulate glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
Geng CD; Vedeckis WV
Biochemistry; 2010 Oct; 49(41):8892-901. PubMed ID: 20831260
[TBL] [Abstract][Full Text] [Related]
28. Identification of genes leading to glucocorticoid-induced leukemic cell death.
Thompson EB; Webb MS; Miller AL; Fofanov Y; Johnson BH
Lipids; 2004 Aug; 39(8):821-5. PubMed ID: 15638253
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
Miller AL; Webb MS; Thompson EB
Steroids; 2007 Sep; 72(9-10):673-81. PubMed ID: 17606285
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types.
Webster JC; Huber RM; Hanson RL; Collier PM; Haws TF; Mills JK; Burn TC; Allegretto EA
Endocrinology; 2002 Oct; 143(10):3866-74. PubMed ID: 12239098
[TBL] [Abstract][Full Text] [Related]
31. The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression.
Lynch JT; Rajendran R; Xenaki G; Berrou I; Demonacos C; Krstic-Demonacos M
Mol Cancer; 2010 Feb; 9():38. PubMed ID: 20156337
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids.
Miller AL; Komak S; Webb MS; Leiter EH; Thompson EB
Cancer Cell Int; 2007 Nov; 7():18. PubMed ID: 18045478
[TBL] [Abstract][Full Text] [Related]
33. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids protect against apoptosis induced by serum deprivation, cyclic adenosine 3',5'-monophosphate and p53 activation in immortalized human granulosa cells: involvement of Bcl-2.
Sasson R; Tajima K; Amsterdam A
Endocrinology; 2001 Feb; 142(2):802-11. PubMed ID: 11159853
[TBL] [Abstract][Full Text] [Related]
35. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
36. Gene networks in glucocorticoid-evoked apoptosis of leukemic cells.
Webb MS; Miller AL; Johnson BH; Fofanov Y; Li T; Wood TG; Thompson EB
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):183-93. PubMed ID: 12943703
[TBL] [Abstract][Full Text] [Related]
37. Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell type-specific and exhibits differential hormonal sensitivity for down- and up-regulation.
Barrett TJ; Vig E; Vedeckis WV
Biochemistry; 1996 Jul; 35(30):9746-53. PubMed ID: 8703946
[TBL] [Abstract][Full Text] [Related]
38. 3',5'-cyclic adenosine monophosphate response element-binding protein and CCAAT enhancer-binding protein are dispensable for insulin inhibition of phosphoenolpyruvate carboxykinase transcription and for its synergistic induction by protein kinase A and glucocorticoids.
Yeagley D; Quinn PG
Mol Endocrinol; 2005 Apr; 19(4):913-24. PubMed ID: 15604115
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
[TBL] [Abstract][Full Text] [Related]
40. Positive and negative regulation of the rat vasopressin gene promoter.
Iwasaki Y; Oiso Y; Saito H; Majzoub JA
Endocrinology; 1997 Dec; 138(12):5266-74. PubMed ID: 9389510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
